CR10431A - Sales y modificaciones del cristal de las mismas - Google Patents
Sales y modificaciones del cristal de las mismasInfo
- Publication number
- CR10431A CR10431A CR10431A CR10431A CR10431A CR 10431 A CR10431 A CR 10431A CR 10431 A CR10431 A CR 10431A CR 10431 A CR10431 A CR 10431A CR 10431 A CR10431 A CR 10431A
- Authority
- CR
- Costa Rica
- Prior art keywords
- salts
- crystal
- modifications
- same
- phenyl
- Prior art date
Links
Classifications
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07D—HETEROCYCLIC COMPOUNDS
- C07D243/00—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms
- C07D243/06—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4
- C07D243/10—Heterocyclic compounds containing seven-membered rings having two nitrogen atoms as the only ring hetero atoms having the nitrogen atoms in positions 1 and 4 condensed with carbocyclic rings or ring systems
- C07D243/14—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines
- C07D243/16—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals
- C07D243/18—1,4-Benzodiazepines; Hydrogenated 1,4-benzodiazepines substituted in position 5 by aryl radicals substituted in position 2 by nitrogen, oxygen or sulfur atoms
- C07D243/24—Oxygen atoms
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61K—PREPARATIONS FOR MEDICAL, DENTAL OR TOILETRY PURPOSES
- A61K31/00—Medicinal preparations containing organic active ingredients
- A61K31/33—Heterocyclic compounds
- A61K31/395—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins
- A61K31/55—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole
- A61K31/551—Heterocyclic compounds having nitrogen as a ring hetero atom, e.g. guanethidine or rifamycins having seven-membered rings, e.g. azelastine, pentylenetetrazole having two nitrogen atoms, e.g. dilazep
- A61K31/5513—1,4-Benzodiazepines, e.g. diazepam or clozapine
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
-
- A—HUMAN NECESSITIES
- A61—MEDICAL OR VETERINARY SCIENCE; HYGIENE
- A61P—SPECIFIC THERAPEUTIC ACTIVITY OF CHEMICAL COMPOUNDS OR MEDICINAL PREPARATIONS
- A61P31/00—Antiinfectives, i.e. antibiotics, antiseptics, chemotherapeutics
- A61P31/12—Antivirals
- A61P31/14—Antivirals for RNA viruses
-
- C—CHEMISTRY; METALLURGY
- C07—ORGANIC CHEMISTRY
- C07B—GENERAL METHODS OF ORGANIC CHEMISTRY; APPARATUS THEREFOR
- C07B2200/00—Indexing scheme relating to specific properties of organic compounds
- C07B2200/13—Crystalline forms, e.g. polymorphs
Landscapes
- Chemical & Material Sciences (AREA)
- Organic Chemistry (AREA)
- Health & Medical Sciences (AREA)
- Life Sciences & Earth Sciences (AREA)
- Veterinary Medicine (AREA)
- Virology (AREA)
- Public Health (AREA)
- General Health & Medical Sciences (AREA)
- Animal Behavior & Ethology (AREA)
- Medicinal Chemistry (AREA)
- Pharmacology & Pharmacy (AREA)
- Communicable Diseases (AREA)
- Nuclear Medicine, Radiotherapy & Molecular Imaging (AREA)
- General Chemical & Material Sciences (AREA)
- Chemical Kinetics & Catalysis (AREA)
- Oncology (AREA)
- Molecular Biology (AREA)
- Epidemiology (AREA)
- Pharmaceuticals Containing Other Organic And Inorganic Compounds (AREA)
Abstract
La invencion se refiere a sales de 1-(2-fluoro-fenil)-3-(2-oxo-5-fenil-2,3-dihidro-1H-benzo[e]-[1,4]-diazepin-3-il)-urea, y a las formas cristalinas de las mismas, a su produccion y uso, y a preparaciones farmaceuticas que contienen estas sales y formas cristalinas.
Applications Claiming Priority (1)
Application Number | Priority Date | Filing Date | Title |
---|---|---|---|
US80283606P | 2006-05-23 | 2006-05-23 |
Publications (1)
Publication Number | Publication Date |
---|---|
CR10431A true CR10431A (es) | 2009-01-07 |
Family
ID=38704747
Family Applications (1)
Application Number | Title | Priority Date | Filing Date |
---|---|---|---|
CR10431A CR10431A (es) | 2006-05-23 | 2008-11-10 | Sales y modificaciones del cristal de las mismas |
Country Status (28)
Country | Link |
---|---|
US (1) | US7977330B2 (es) |
EP (1) | EP2029556B1 (es) |
JP (2) | JP2009538330A (es) |
KR (1) | KR20090009898A (es) |
CN (1) | CN101448796B (es) |
AR (1) | AR061056A1 (es) |
AT (1) | ATE486858T1 (es) |
AU (1) | AU2007267671A1 (es) |
BR (1) | BRPI0712556A2 (es) |
CA (1) | CA2650514A1 (es) |
CL (1) | CL2007001454A1 (es) |
CR (1) | CR10431A (es) |
DE (1) | DE602007010286D1 (es) |
EC (1) | ECSP088900A (es) |
ES (1) | ES2355166T3 (es) |
GT (1) | GT200800253A (es) |
IL (1) | IL195008A0 (es) |
MA (1) | MA30482B1 (es) |
MX (1) | MX2008014836A (es) |
NO (1) | NO20085000L (es) |
PE (1) | PE20080261A1 (es) |
PL (1) | PL2029556T3 (es) |
PT (1) | PT2029556E (es) |
RU (1) | RU2008150627A (es) |
TN (1) | TNSN08477A1 (es) |
TW (1) | TW200815375A (es) |
WO (1) | WO2007140154A2 (es) |
ZA (1) | ZA200809096B (es) |
Family Cites Families (1)
Publication number | Priority date | Publication date | Assignee | Title |
---|---|---|---|---|
PL375860A1 (en) * | 2002-09-20 | 2005-12-12 | Arrow Therapeutics Limited | Benzodiazepine derivatives and pharmaceutical compositions containing them |
-
2007
- 2007-05-21 DE DE602007010286T patent/DE602007010286D1/de active Active
- 2007-05-21 AR ARP070102191A patent/AR061056A1/es unknown
- 2007-05-21 EP EP07797606A patent/EP2029556B1/en active Active
- 2007-05-21 JP JP2009512241A patent/JP2009538330A/ja active Pending
- 2007-05-21 AT AT07797606T patent/ATE486858T1/de active
- 2007-05-21 MX MX2008014836A patent/MX2008014836A/es not_active Application Discontinuation
- 2007-05-21 BR BRPI0712556-9A patent/BRPI0712556A2/pt not_active Application Discontinuation
- 2007-05-21 RU RU2008150627/04A patent/RU2008150627A/ru not_active Application Discontinuation
- 2007-05-21 CA CA002650514A patent/CA2650514A1/en not_active Abandoned
- 2007-05-21 AU AU2007267671A patent/AU2007267671A1/en not_active Abandoned
- 2007-05-21 PE PE2007000619A patent/PE20080261A1/es not_active Application Discontinuation
- 2007-05-21 PT PT07797606T patent/PT2029556E/pt unknown
- 2007-05-21 US US12/298,203 patent/US7977330B2/en not_active Expired - Fee Related
- 2007-05-21 PL PL07797606T patent/PL2029556T3/pl unknown
- 2007-05-21 CN CN2007800181255A patent/CN101448796B/zh not_active Expired - Fee Related
- 2007-05-21 ES ES07797606T patent/ES2355166T3/es active Active
- 2007-05-21 KR KR1020087028592A patent/KR20090009898A/ko not_active Application Discontinuation
- 2007-05-21 WO PCT/US2007/069327 patent/WO2007140154A2/en active Application Filing
- 2007-05-22 TW TW096118228A patent/TW200815375A/zh unknown
- 2007-05-22 CL CL200701454A patent/CL2007001454A1/es unknown
-
2008
- 2008-10-23 ZA ZA200809096A patent/ZA200809096B/xx unknown
- 2008-10-30 IL IL195008A patent/IL195008A0/en unknown
- 2008-11-10 CR CR10431A patent/CR10431A/es not_active Application Discontinuation
- 2008-11-21 TN TNP2008000477A patent/TNSN08477A1/en unknown
- 2008-11-21 GT GT200800253A patent/GT200800253A/es unknown
- 2008-11-21 EC EC2008008900A patent/ECSP088900A/es unknown
- 2008-11-26 MA MA31419A patent/MA30482B1/fr unknown
- 2008-11-28 NO NO20085000A patent/NO20085000L/no not_active Application Discontinuation
-
2013
- 2013-01-04 JP JP2013000196A patent/JP2013075910A/ja not_active Withdrawn
Also Published As
Publication number | Publication date |
---|---|
MX2008014836A (es) | 2008-12-01 |
TW200815375A (en) | 2008-04-01 |
ZA200809096B (en) | 2009-11-25 |
GT200800253A (es) | 2009-04-29 |
KR20090009898A (ko) | 2009-01-23 |
PL2029556T3 (pl) | 2011-04-29 |
US7977330B2 (en) | 2011-07-12 |
WO2007140154A3 (en) | 2008-03-20 |
AR061056A1 (es) | 2008-07-30 |
ES2355166T3 (es) | 2011-03-23 |
DE602007010286D1 (de) | 2010-12-16 |
TNSN08477A1 (en) | 2010-04-14 |
RU2008150627A (ru) | 2010-06-27 |
CA2650514A1 (en) | 2007-12-06 |
JP2013075910A (ja) | 2013-04-25 |
CN101448796A (zh) | 2009-06-03 |
PE20080261A1 (es) | 2008-04-18 |
CN101448796B (zh) | 2012-09-26 |
IL195008A0 (en) | 2009-08-03 |
ECSP088900A (es) | 2008-12-30 |
AU2007267671A1 (en) | 2007-12-06 |
BRPI0712556A2 (pt) | 2013-07-02 |
WO2007140154A2 (en) | 2007-12-06 |
EP2029556A2 (en) | 2009-03-04 |
CL2007001454A1 (es) | 2008-05-16 |
EP2029556B1 (en) | 2010-11-03 |
MA30482B1 (fr) | 2009-06-01 |
PT2029556E (pt) | 2011-01-31 |
US20090163478A1 (en) | 2009-06-25 |
JP2009538330A (ja) | 2009-11-05 |
NO20085000L (no) | 2008-12-23 |
ATE486858T1 (de) | 2010-11-15 |
Similar Documents
Publication | Publication Date | Title |
---|---|---|
UY31468A1 (es) | Derivados bis-(sulfonilamino) en terapia 065 | |
ECSP10010178A (es) | Derivados bis-(sulfonilamino) en terapia 066 | |
UY30327A1 (es) | Nuevos compuestos ii | |
UY31546A1 (es) | Derivados bis-(sulfonilamino) en terapia 205 | |
UY30328A1 (es) | Derivados de 2-piridona, procesos de preparacion, composiciones conteniéndolos y aplicaciones. | |
BR122019010008B8 (pt) | derivados de pirimidina, seu uso, e composição e combinação farmacêuticas | |
UY31456A1 (es) | Derivados de 2-pirazinona como inhibidores de la elastasa de los neutrofilos | |
UY29549A1 (es) | Nuevos derivados del fluoreno, composiciones que los contienen y su utilización | |
NI200800020A (es) | 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización. | |
ECSP066365A (es) | Anilino purinas sustituidas en la posición 6 útiles como inhibidores de rtk | |
UY29037A1 (es) | Nuevos derivados de urea cíclicos sustituidos con heterociclo, su preparación y su uso farmacéutico como inhibidores de quinasa | |
ECSP088666A (es) | Derivados de las benzamidas y heteroarenos | |
ECSP078030A (es) | Formas cristalinas y otras formas de las sales de ácido láctico de 4-amino-5-fluoro-3-[6-(4-metilpiperazin -1-il)-1h-bencimidazol-2 -il]-1h-quinolin-2-ona | |
CR10027A (es) | Nuevos derivados de pirrol fusionado | |
NI200800217A (es) | Arildihidroisoquinolinonas sustituidas con azaciclilo, procedimiento para su preparación y su uso como medicamentos. | |
AR077478A2 (es) | Derivados de oxindol sustituido medicamentos que los comprenden y uso de los mismos | |
UY30856A1 (es) | Nuevos derivados de 2,4 dianilinopirimidinas, su preparacion, como medicamentos, composiciones farmacéuticas y principalmente como inhibidores de ikk | |
UY29468A1 (es) | Nuevos derivados de isoindoles, composiciones que los contienen, su preparación y sus utilizaciones farmacéuticas, especialmente como inhibidores de las actividades de la proteína chaperona hsp90. | |
PA8654701A1 (es) | Indoles sustituidos, composiciones que los contienen, procedimiento de fabricacion y utilizacion | |
UY30289A1 (es) | Derivados de la 1h-pirrol-3-carboxamida sustituida con 1-(tetrahidro-2h-piran-4-il-metil)-1h-bencimidazol, composiciones conteniéndolos, procedimientos de preparacion y aplicaciones | |
ECSP088252A (es) | 7-aza-indazoles sustituidos, composiciones que los contienen, procedimiento de fabricación y utilización | |
UY27410A1 (es) | Formas novedosas crudas cristalinas | |
BRPI0415203A (pt) | pentanóis reestruturados, um processo para sua produção e seu uso como agentes antiinflamatórios | |
ECSP088603A (es) | Nuevas n-(fluor-pirazinil)-fenilsulfonamidas como moduladores del receptor de quimioquina ccr4 | |
UY29804A1 (es) | Quinolinas de alquilnitrilo |
Legal Events
Date | Code | Title | Description |
---|---|---|---|
FA | Abandonment or withdrawal (granting procedure) |